{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:19:14Z","timestamp":1791897554640,"version":"4.3.4"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s11938-017-0151-1","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T04:08:25Z","timestamp":1508818105000},"page":"460-474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Diabetes Mellitus and the Colon"],"prefix":"10.1007","volume":"15","author":[{"given":"Marc S.","family":"Piper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"key":"151_CR1","unstructured":"National Center for Chronic Disease Prevention and Health Promotion, Division of Diabetes Translation. In: Diabetes Home. Centers for Disease Control and Prevention. 2017. https:\/\/www.cdc.gov\/diabetes\/data\/index.html . Last Updated: 12 Jan 2017."},{"issue":"2","key":"151_CR2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","volume":"103","author":"L Guariguata","year":"2014","unstructured":"Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137\u201349.","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"151_CR3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11892-015-0672-8","volume":"15","author":"VJ Horv\u00e1th","year":"2015","unstructured":"Horv\u00e1th VJ, Putz Z, Izb\u00e9ki F, et al. Diabetes-related dysfunction of the small intestine and the colon: focus on motility. Curr Diab Rep. 2015;15(11):94.","journal-title":"Curr Diab Rep"},{"issue":"4","key":"151_CR4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ecl.2016.06.005","volume":"45","author":"F Bril","year":"2016","unstructured":"Bril F, Cusi K. Nonalcoholic fatty liver disease. Endocrinol Metab Clin N Am. 2016;45(4):765\u201381.","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"5","key":"151_CR5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4239\/wjd.v6.i5.707","volume":"6","author":"A Akirov","year":"2015","unstructured":"Akirov A. Co-occurrence of type 1 diabetes mellitus and celiac disease. World J Diabetes. 2015;6(5):707.","journal-title":"World J Diabetes"},{"key":"151_CR6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.7326\/0003-4819-98-3-378","volume":"98","author":"M Feldman","year":"1983","unstructured":"Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med. 1983;98:378\u201384.","journal-title":"Ann Intern Med"},{"key":"151_CR7","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1001\/archinte.161.16.1989","volume":"161","author":"P Bytzer","year":"2001","unstructured":"Bytzer P, Talley NG, Leemon M, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 1500 adults. Arch Intern Med. 2001;161:1989\u201396.","journal-title":"Arch Intern Med"},{"key":"151_CR8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s13300-016-0182-y","volume":"7","author":"A Maisey","year":"2016","unstructured":"Maisey A. A practical approach to gastrointestinal complications of diabetes. Diab Ther. 2016;7:379\u201386.","journal-title":"Diab Ther"},{"issue":"5","key":"151_CR9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/nmo.12330","volume":"26","author":"SS Yarandi","year":"2014","unstructured":"Yarandi SS, Srinivasan S. Diabetic gastrointestinal motility disorders and the role of the enteric nervous system: current status and future directions. Neurogastroenterol Motil. 2014;26(5):611\u201324.","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"151_CR10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1365-2613.2011.00789.x","volume":"92","author":"A Dom\u00e8nech","year":"2011","unstructured":"Dom\u00e8nech A, Pasquinelli G, De Giorgio R, et al. Morphofunctional changes underlying intestinal dysmotility in diabetic RIP-I\/hIFN\u03b2 transgenic mice. Int J Exp Pathol. 2011;92(6):400\u201312.","journal-title":"Int J Exp Pathol"},{"issue":"11","key":"151_CR11","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2982.2009.01379.x","volume":"21","author":"F Du","year":"2009","unstructured":"Du F, Wang L, Qian W, et al. Loss of enteric neurons accompanied by decreased expression of GDNF and PI3K\/Akt pathway in diabetic rats. Neurogastroenterol Motil. 2009;21(11):1229\u2013e114.","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"151_CR12","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1590\/S0004-282X2002000400012","volume":"60","author":"MMDP Furlan","year":"2002","unstructured":"Furlan MMDP, Molinari SL, Neto M, et al. Morphoquantitative effects of acute diabetes on the myenteric neurons of the proximal colon of adults rats. Arq Neuro Psiquiatr. 2002;60(3):576\u201381.","journal-title":"Arq Neuro Psiquiatr"},{"issue":"6","key":"151_CR13","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1046\/j.1440-1746.2002.02756.x","volume":"17","author":"M Nakahara","year":"2002","unstructured":"Nakahara M, Isozaki K, Hirota S, et al. Deficiency of KIT-positive cells in the colon of patients with diabetes mellitus. J Gastroenterol Hepatol. 2002;17(6):666\u201370.","journal-title":"J Gastroenterol Hepatol"},{"key":"151_CR14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12990-015-0075-5","volume":"11","author":"L Dong","year":"2015","unstructured":"Dong L, Liang X, Sun B, et al. Impairments of the primary afferent nerves in a rat model of diabetic visceral hyposensitivity. Mol Pain. 2015;11:74.","journal-title":"Mol Pain"},{"issue":"6","key":"151_CR15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4239\/wjd.v8.i6.249","volume":"8","author":"M Zhao","year":"2017","unstructured":"Zhao M, Liao D, Zhao J. Diabetes-induced mechanophysiological changes in the small intestine and colon. World J Diabetes. 2017;8(6):249\u201369.","journal-title":"World J Diabetes"},{"issue":"3","key":"151_CR16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00125-015-3831-1","volume":"59","author":"F Azpiroz","year":"2016","unstructured":"Azpiroz F, Malagelada C. Diabetic neuropathy in the gut: pathogenesis and diagnosis. Diabetologia. 2016;59(3):404\u20138.","journal-title":"Diabetologia"},{"issue":"4","key":"151_CR17","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/j.1572-0241.2001.03738.x","volume":"96","author":"AF Celik","year":"2001","unstructured":"Celik AF, Osar Z, Damci T, et al. How important are the disturbances of lower gastrointestinal bowel habits in diabetic outpatients? Am J Gastroenterol. 2001;96(4):1314\u20136.","journal-title":"Am J Gastroenterol"},{"key":"151_CR18","first-page":"637","volume":"32","author":"P Enck","year":"1994","unstructured":"Enck P, Rathmann W, Spiekermann M, et al. Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol. 1994;32:637\u201341.","journal-title":"Z Gastroenterol"},{"issue":"18","key":"151_CR19","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1001\/archinte.160.18.2808","volume":"160","author":"D Maleki","year":"2000","unstructured":"Maleki D, Locke GR, Camilleri M, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000;160(18):2808\u201316.","journal-title":"Arch Intern Med"},{"issue":"11","key":"151_CR20","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1023\/A:1026657426396","volume":"43","author":"D Maleki","year":"1998","unstructured":"Maleki D, Camilleri M, Burton DD, et al. Pilot study of pathophysiology of constipation among community diabetics. Dig Dis Sci. 1998;43(11):2373\u20138.","journal-title":"Dig Dis Sci"},{"issue":"793","key":"151_CR21","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/pgmj.67.793.991","volume":"67","author":"DG Maxton","year":"1991","unstructured":"Maxton DG, Whorwell PG. Functional bowel symptoms in diabetes: the role of autonomic neuropathy. Postgrad Med J. 1991;67(793):991\u20133.","journal-title":"Postgrad Med J"},{"issue":"1","key":"151_CR22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12664-016-0724-2","volume":"36","author":"VGM Prasad","year":"2017","unstructured":"\u2022 Prasad VGM, Abraham P. Management of chronic constipation in patients with diabetes mellitus. Indian J Gastroenterol. 2017;36(1):11\u201322. A recent and comprehensive review that discusses the treatment of constipation in diabetics","journal-title":"Indian J Gastroenterol"},{"issue":"1","key":"151_CR23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.gastro.2012.10.028","volume":"144","author":"AE Bharucha","year":"2013","unstructured":"Bharucha AE, Pemberton JH, Locke GR III. American Gastroenterological Association technical review on constipation. Gastroenterology. 2013;144(1):218\u201338.","journal-title":"Gastroenterology"},{"issue":"6","key":"151_CR24","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1053\/j.gastro.2016.02.009","volume":"150","author":"SSC Rao","year":"2016","unstructured":"Rao SSC, Bharucha AE, Chiarioni G, et al. Anorectal disorders. Gastroenterology. 2016;150(6):1430\u201342.","journal-title":"Gastroenterology"},{"issue":"1","key":"151_CR25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2982.2010.01612.x","volume":"23","author":"SSC Rao","year":"2011","unstructured":"Rao SSC, Camilleri M, Hasler WL, et al. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil. 2011;23(1):8\u201323.","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"151_CR26","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.biotechadv.2011.08.008","volume":"29","author":"PS Panesar","year":"2001","unstructured":"Panesar PS, Kumari S. Lactulose: production, purification and potential applications. Biotechnol Adv. 2001;29(6):940\u20138.","journal-title":"Biotechnol Adv"},{"key":"151_CR27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJMoa1010863","volume":"365","author":"AJ Lembo","year":"2011","unstructured":"Lembo AJ, Schneier HA, Shiff SJ, et al. Two randomized trials of linaclotide for chronic constipation. N Engl J Med. 2011;365:527\u201336.","journal-title":"N Engl J Med"},{"issue":"4","key":"151_CR28","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ajg.2016.611","volume":"112","author":"PB Miner Jr","year":"2017","unstructured":"Miner PB Jr, Koltun WD, Wiener GJ, et al. A randomized phase III clinical trial of plecanatide, a uroguanylin analog, in patients with chronic idiopathic constipation. Am J Gastroenterol. 2017;112(4):613\u201321.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"151_CR29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ajg.2016.531","volume":"112","author":"J Christie","year":"2017","unstructured":"\u2022\u2022 Christie J, Shroff S, Shahnavaz N, et al. A randomized, double-blind, placebo-controlled trial to examine the effectiveness of lubiprostone on constipation symptoms and colon transit time in diabetic patients. Am J Gastroenterol. 2017;112(2):356\u201364. Randomized, controlled trial (lubiprostone versus placebo) which demonstrates the effectiveness of lubiprostone in improving colonic transit time and bowel function in diabetic patients.","journal-title":"Am J Gastroenterol"},{"key":"151_CR30","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMoa0800670","volume":"358","author":"M Camilleri","year":"2008","unstructured":"Camilleri M, Kerstens R, Rykx A, et al. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med. 2008;358:2344\u201354.","journal-title":"N Engl J Med"},{"issue":"5","key":"151_CR31","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/gutjnl-2012-302483","volume":"62","author":"AE Bharucha","year":"2013","unstructured":"\u2022\u2022 Bharucha AE, Low P, Camilleri M, et al. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Gut. 2013;62(5):708\u201315. Randomized, controlled trial (pyridostigmine versus placebo) which shows improvement in colonic transit time and bowel function in diabetic patients (without defecatory disorders) on pyridostigmine.","journal-title":"Gut"},{"issue":"8","key":"151_CR32","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1111\/j.1572-0241.1999.01289.x","volume":"94","author":"J Lysy","year":"1999","unstructured":"Lysy J. The prevalence of chronic diarrhea among diabetic patients. Am J Gastroenterol. 1999;94(8):2165\u201370.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"151_CR33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cgh.2016.07.028","volume":"15","author":"LR Schiller","year":"2017","unstructured":"Schiller LR, Pardi DS, Sellin JH. Chronic diarrhea: diagnosis and management. Clin Gastroenterol Hepatol. 2017;15(2):182\u201393.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"151_CR34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s11894-009-0056-9","volume":"11","author":"F Fern\u00e1ndez-Ba\u00f1ares","year":"2009","unstructured":"Fern\u00e1ndez-Ba\u00f1ares F, Esteve M, Viver JM. Fructose-sorbitol malabsorption. Curr Gastroenterol Rep. 2009;11(5):368\u201374.","journal-title":"Curr Gastroenterol Rep"},{"issue":"5","key":"151_CR35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11894-009-0054-y","volume":"11","author":"M Gould","year":"2009","unstructured":"Gould M, SellinJH. Diabetic diarrhea. Curr Gastroenterol Rep. 2009;11(5):354\u20139.","journal-title":"Curr Gastroenterol Rep"},{"issue":"1","key":"151_CR36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.gastro.2013.09.046","volume":"146","author":"EP Halmos","year":"2014","unstructured":"Halmos EP, Power VA, Shepherd SJ, et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014;146(1):67\u201375.","journal-title":"Gastroenterology"},{"issue":"5","key":"151_CR37","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jdiacomp.2017.01.011","volume":"31","author":"M Hansen","year":"2017","unstructured":"Hansen M, Sonne DP, Mikkelsen KH, et al. Bile acid sequestrants for glycemic control in patients with type 2 diabetes: a systematic review with meta-analysis of randomized controlled trials. J Diabetes Complicat. 2017;31(5):918\u201327.","journal-title":"J Diabetes Complicat"},{"key":"151_CR38","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/ajg.2008.122","volume":"104","author":"LJ Brandt","year":"2008","unstructured":"Brandt LJ, Chey WD, Foxx-Orenstein AE, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol. 2008;104:S1\u2013S35.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"151_CR39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-102-2-197","volume":"102","author":"RN Fedorak","year":"1985","unstructured":"Fedorak RN. Treatment of diabetic diarrhea with clonidine. Ann Intern Med. 1985;102(2):197\u20139.","journal-title":"Ann Intern Med"},{"issue":"3","key":"151_CR40","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1756283X15625586","volume":"9","author":"KC Fragkos","year":"2016","unstructured":"Fragkos KC, Z\u00e1rate-Lopez N, Frangos CC. What about clonidine for diarrhoea? A systematic review and meta-analysis of its effect in humans. Ther Adv Gastroenterol. 2016;9(3):282\u2013301.","journal-title":"Ther Adv Gastroenterol"},{"key":"151_CR41","first-page":"680","volume":"42","author":"G Bretzke","year":"1987","unstructured":"Bretzke G. Therapy of diarrhea in diabetic enteropathy with clonidine. Z Gesante Inn Med. 1987;42:680\u20132.","journal-title":"Z Gesante Inn Med"},{"issue":"8","key":"151_CR42","first-page":"995","volume":"86","author":"GA Morali","year":"1991","unstructured":"Morali GA, Braverman DZ, Lissi J, et al. Effect of clonidine on gallbladder contraction and small bowel transit time in insulin-treated diabetics. Am J Gastroenterol. 1991;86(8):995\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"151_CR43","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1136\/gut.33.11.1578","volume":"33","author":"FH Mourad","year":"1992","unstructured":"Mourad FH, Gorard D, Thillainayagam AV, et al. Effective treatment of diabetic diarrhoea with somatostatin analogue, octreotide. Gut. 1992;33(11):1578\u201380.","journal-title":"Gut"},{"issue":"16","key":"151_CR44","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/archinte.1994.00420160103014","volume":"154","author":"H Nakabayashi","year":"1994","unstructured":"Nakabayashi H. Marked improvement of diabetic diarrhea with the somatostatin analogue octreotide. Arch Intern Med. 1994;154(16):1863\u20137.","journal-title":"Arch Intern Med"},{"issue":"6","key":"151_CR45","doi-asserted-by":"crossref","first-page":"894","DOI":"10.7326\/0003-4819-104-6-894_1","volume":"104","author":"ST Tsai","year":"1986","unstructured":"Tsai ST. Diabetic diarrhea and somatostatin. Ann Intern Med. 1986;104(6):894.","journal-title":"Ann Intern Med"},{"issue":"3","key":"151_CR46","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.2337\/dc09-2131","volume":"33","author":"S Murao","year":"2010","unstructured":"Murao S, Hosokawa H. Serotonin 5-HT3 receptor antagonist for treatment of severe diabetic diarrhea. Diabetes Care. 2010;33(3):e38.","journal-title":"Diabetes Care"},{"issue":"5","key":"151_CR47","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/diacare.17.5.453b","volume":"17","author":"A Bossi","year":"1994","unstructured":"Bossi A, Baresi A, Ballini A, et al. Ondasentron in the treatment of diabetic diarrhea. Diabetes Care. 1994;17(5):453\u20134.","journal-title":"Diabetes Care"},{"issue":"1","key":"151_CR48","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3904\/kjim.2013.28.1.106","volume":"28","author":"TH Lee","year":"2013","unstructured":"Lee TH, Lee JS. Ramosetron might be useful for treating diabetic diarrhea with a rapid small bowel transit time. Korean J Intern Med. 2013;28(1):106\u20137.","journal-title":"Korean J Intern Med"},{"issue":"10","key":"151_CR49","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/gutjnl-2013-305989","volume":"63","author":"K Garsed","year":"2014","unstructured":"Garsed K, Chernova J, Hastings M, et al. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014;63(10):1617\u201325.","journal-title":"Gut"},{"issue":"23","key":"151_CR50","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1001\/jama.2008.824","volume":"300","author":"BB Barone","year":"2008","unstructured":"Barone BB, Yeh HC, Snyder CF, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008;300(23):2754\u201364.","journal-title":"JAMA"},{"key":"151_CR51","doi-asserted-by":"crossref","first-page":"46527","DOI":"10.1038\/srep46527","volume":"7","author":"S Kort de","year":"2017","unstructured":"de Kort S, Masclee AA, Sanduleanu S, et al. Higher risk of colorectal cancer in patients with newly diagnosed diabetes mellitus before the age of colorectal cancer screening initiation. Sci Rep. 2017;7:46527.","journal-title":"Sci Rep"},{"issue":"3","key":"151_CR52","doi-asserted-by":"crossref","first-page":"836S","DOI":"10.1093\/ajcn\/86.3.836S","volume":"86","author":"E Giovannucci","year":"2007","unstructured":"Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007;86(3):836S\u201342S.","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"151_CR53","doi-asserted-by":"crossref","first-page":"18456","DOI":"10.18632\/oncotarget.14472","volume":"8","author":"N Gonz\u00e1lez","year":"2017","unstructured":"Gonz\u00e1lez N, Prieto I, del Puerto-Nevado L, et al. 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications. Oncotarget. 2017;8(11):18456\u201385.","journal-title":"Oncotarget"},{"key":"151_CR54","doi-asserted-by":"crossref","first-page":"g7607","DOI":"10.1136\/bmj.g7607","volume":"350","author":"KK Tsilidis","year":"2015","unstructured":"Tsilidis KK, Kasimis JC, Lopez DS, et al. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607.","journal-title":"BMJ"},{"issue":"4","key":"151_CR55","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3322\/caac.20078","volume":"60","author":"E Giovannuci","year":"2010","unstructured":"Giovannuci E, Harlan DM, Arhcer MC, et al. Diabetes and cancer. A consensus report. CA Cancer J Clin. 2010;60(4):207\u201321.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"151_CR56","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF00052777","volume":"6","author":"E Giovannucci","year":"1995","unstructured":"Giovannucci E. Insulin and colon cancer. Cancer Causes Control. 1995;6(2):164\u201379.","journal-title":"Cancer Causes Control"},{"issue":"10","key":"151_CR57","first-page":"3259","volume":"8","author":"N Reinmuth","year":"2002","unstructured":"Reinmuth N, Liu W, Fan F, et al. Blockade of insulin-like growth factor I receptor function inhibits growth and angiogensis of colon cancer. Clin Canc Res. 2002;8(10):3259\u201369.","journal-title":"Clin Canc Res"},{"issue":"3","key":"151_CR58","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.2003.07.125","volume":"21","author":"JA Meyerhardt","year":"2016","unstructured":"Meyerhardt JA, Catalano PJ, Haller DG, et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2016;21(3):433\u201340.","journal-title":"J Clin Oncol"},{"issue":"7","key":"151_CR59","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s10620-009-0944-8","volume":"55","author":"KB Stein","year":"2010","unstructured":"Stein KB, Snyder CF, Barone BB, et al. Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Dig Dis Sci. 2010;55(7):1839\u201351.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"151_CR60","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1245\/s10434-015-5028-8","volume":"23","author":"T Fransgaard","year":"2016","unstructured":"Fransgaard T, Thygesen LC, G\u00f6genur I. Metformin increases overall survival in patients with diabetes undergoing surgery for colorectal cancer. Ann Surg Oncol. 2016;23(5):1569\u201375.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"151_CR61","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1089\/sur.2016.258","volume":"18","author":"EC Paulson","year":"2017","unstructured":"Paulson EC, Thompson E, Mahmoud N. Surgical site infection and colorectal surgical procedures: a prospective analysis of risk factors. Surg Infect. 2017;18(4):520\u20136.","journal-title":"Surg Infect"},{"issue":"8","key":"151_CR62","doi-asserted-by":"crossref","first-page":"e71583","DOI":"10.1371\/journal.pone.0071583","volume":"8","author":"M Franciosi","year":"2013","unstructured":"Franciosi M, Lucisano G, Lapice E, et al. Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review. PLoS One. 2013;8(8):e71583.","journal-title":"PLoS One"},{"issue":"2","key":"151_CR63","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2337\/dc09-1380","volume":"33","author":"GWD Landman","year":"2010","unstructured":"Landman GWD, van Hateren KN, et al. Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care. 2010;33(2):322\u20136.","journal-title":"Diabetes Care"},{"issue":"1","key":"151_CR64","first-page":"C15","volume":"5","author":"L Wu","year":"2015","unstructured":"Wu L, Zhu J, Prokop LG, et al. Pharmacologic therapy of diabetes and overall cancer risk and mortality: a meta-analysis of 265 studies. Sci Rep. 2015;5(1):C15.","journal-title":"Sci Rep"},{"issue":"4","key":"151_CR65","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(15)00565-3","volume":"17","author":"T Higurashi","year":"2016","unstructured":"Higurashi T, Hosono K, Takahashi H, et al. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial. Lancet Oncol. 2016;17(4):475\u201383.","journal-title":"Lancet Oncol"},{"issue":"3","key":"151_CR66","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.gie.2014.09.066","volume":"81","author":"VK Dik","year":"2015","unstructured":"Dik VK, LMG M, Hyk M, et al. Predicting inadequate bowel preparation for colonoscopy in participants receiving split-dose bowel preparation: development and validation of a prediction score. Gastrointest Endosc. 2015;81(3):665\u201372.","journal-title":"Gastrointest Endosc"},{"issue":"816","key":"151_CR67","first-page":"1","volume":"93","author":"D Mandolesi","year":"2017","unstructured":"Mandolesi D, Frazzoni L, Bazzoli F, et al. The management of \u201chard-to-prepare\u201d colonoscopy patients. Expert Rev Gastroenterol Hepatol. 2017;93(816):1\u201310.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"12","key":"151_CR68","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00384-009-0757-4","volume":"24","author":"NA Ozturk","year":"2009","unstructured":"Ozturk NA, Gokturk HS, Demir M, et al. The effect of autonomous neuropathy on bowel preparation in type 2 diabetes mellitus. Int J Color Dis. 2009;24(12):1407\u201312.","journal-title":"Int J Color Dis"},{"key":"151_CR69","doi-asserted-by":"crossref","first-page":"150391","DOI":"10.5888\/pcd13.150391","volume":"13","author":"NR Porter","year":"2016","unstructured":"Porter NR, Eberth JM, Samson ME, et al. Peer reviewed: diabetes status and being up-to-date on colorectal cancer screening, 2012 behavioral risk factor surveillance system. Prev Chronic Dis. 2016;13:150391.","journal-title":"Prev Chronic Dis"},{"issue":"5","key":"151_CR70","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/SGA.0b013e31822c3a24","volume":"34","author":"A Hayes","year":"2001","unstructured":"Hayes A, Buffum M, Hughes J. Diabetic colon preparation comparison study. Gastroenterol Nurs. 2001;34(5):377\u201382.","journal-title":"Gastroenterol Nurs"},{"issue":"3","key":"151_CR71","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MCG.0000000000000536","volume":"51","author":"YH Kim","year":"2017","unstructured":"Kim YH, Seo EH, Lee JS, et al. Inadequate bowel cleansing efficacy of split-dose polyethylene glycol for colonoscopy in type 2 diabetic patients: a prospective and blinded study. J Clin Gastroenterol. 2017;51(3):240\u20136.","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"151_CR72","first-page":"203","volume":"49","author":"MA Alvarez-Gonzalez","year":"2017","unstructured":"Alvarez-Gonzalez MA, Flores-Le Roux JA. Bowel preparation for colonoscopy in diabetic patients. Dis Colon Rectum. 2017;49(2):203\u20134.","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"151_CR73","first-page":"202","volume":"49","author":"A Panarese","year":"2017","unstructured":"Panarese A. Bowel preparation in diabetic patients undergoing colonoscopy. Dis Colon Rectum. 2017;49(2):202.","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"151_CR74","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ajg.2016.477","volume":"112","author":"DS Pardi","year":"2016","unstructured":"Pardi DS. Diagnosis and management of microscopic colitis. Am J Gastroenterol. 2016;112(1):78\u201385.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"151_CR75","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/j.gastro.2015.11.006","volume":"150","author":"DS Pardi","year":"2016","unstructured":"Pardi DS, Tremaine WJ, Carrasco-Labra A. American Gastroenterological Association institute technical review on the medical management of microscopic colitis. Gastroenterology. 2016;150(1):247\u201374.","journal-title":"Gastroenterology"},{"issue":"8","key":"151_CR76","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3109\/00365521.2013.805809","volume":"48","author":"L Vigren","year":"2013","unstructured":"Vigren L, Tysk C, Str\u00f6m M, et al. Celiac disease and other autoimmune diseases in patients with collagenous colitis. Scand J Gastroenterol. 2013;48(8):944\u201350.","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"151_CR77","first-page":"411","volume":"19","author":"F Fern\u00e1ndez-Ba\u00f1ares","year":"2013","unstructured":"Fern\u00e1ndez-Ba\u00f1ares F, de Sousa MR, Salas A, et al. Epidemiological risk factors in microscopic colitis: a prospective case\u2013control study. Inflamm Bowel Dis. 2013;19(2):411.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"151_CR78","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/j.gastro.2015.11.008","volume":"150","author":"GC Nguyen","year":"2016","unstructured":"Nguyen GC, Smalley WE, Vege SS, et al. American Gastroenterological Association Institute guideline on the medical management of microscopic colitis. Gastroenterology. 2016;150(1):242\u20136.","journal-title":"Gastroenterology"},{"issue":"29","key":"151_CR79","doi-asserted-by":"crossref","first-page":"8804","DOI":"10.3748\/wjg.v21.i29.8804","volume":"21","author":"T Park","year":"2015","unstructured":"Park T. Microscopic colitis: a review of etiology, treatment and refractory disease. World J Gastroenterol. 2015;21(29):8804.","journal-title":"World J Gastroenterol"},{"issue":"S1","key":"151_CR80","doi-asserted-by":"crossref","first-page":"A208","DOI":"10.1136\/gut.2011.239301.438","volume":"60","author":"JS Leeds","year":"2011","unstructured":"Leeds JS, Hopper AD, Hadjivassiliou M, et al. Inflammatory bowel disease is more common in type 1 diabetes mellitus. Gut. 2011;60(S1):A208.","journal-title":"Gut"},{"issue":"13","key":"151_CR81","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.3748\/wjg.v20.i13.3507","volume":"20","author":"G Maconi","year":"2014","unstructured":"Maconi G, Furfaro F, Sciurti R, et al. Glucose intolerance and diabetes mellitus in ulcerative colitis: pathogenetic and therapeutic implications. World J Gastroenterol. 2014;20(13):3507\u201315.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"151_CR82","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jamcollsurg.2010.09.011","volume":"212","author":"R Sehgal","year":"2011","unstructured":"Sehgal R, Berg A, Figueroa R, et al. Risk factors for surgical site infections after colorectal resection in diabetic patients. J Am Coll Surg. 2011;212(1):29\u201334.","journal-title":"J Am Coll Surg"},{"key":"151_CR83","first-page":"S19","volume":"23","author":"T Teslova","year":"2017","unstructured":"Teslova T, Kim M, Lukin D. Diabetes is associated with worse outcomes in inflammatory bowel disease. Inflamm Bowel Dis. 2017;23:S19.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"151_CR84","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/000313481207800442","volume":"78","author":"BA Coakley","year":"2012","unstructured":"Coakley BA, Divino CM. Identifying factors predictive of surgical-site infections after colectomy for fulminant ulcerative colitis. Am Surg. 2012;78(4):481\u20134.","journal-title":"Am Surg"},{"issue":"6","key":"151_CR85","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10096-015-2348-3","volume":"34","author":"N Eliakim-Raz","year":"2015","unstructured":"Eliakim-Raz N, Fishman G, Yahav D, et al. Predicting Clostridium difficile infection in diabetic patients and the effect of metformin therapy: a retrospective, case\u2013control study. Eur J Clin Microbiol Infect Dis. 2015;34(6):1201\u20135.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"151_CR86","first-page":"112","volume":"64","author":"MC Luca","year":"2016","unstructured":"Luca MC, Rosu F, Hurmuzache M, et al. Updates in the assessment of risk factors in clostridium difficile infection in patients with infectious diseases. Farmacia. 2016;64(1):112\u20135.","journal-title":"Farmacia"},{"issue":"3","key":"151_CR87","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajic.2010.08.017","volume":"39","author":"R Shakov","year":"2011","unstructured":"Shakov R, Salazar RS, Kagunye SK, et al. Diabetes mellitus as a risk factor for recurrence of Clostridium difficile infection in the acute care hospital setting. Am J Infect Control. 2011;39(3):194\u20138.","journal-title":"Am J Infect Control"},{"issue":"S2","key":"151_CR88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12418","volume":"20","author":"SB Debast","year":"2014","unstructured":"Debast SB, Bauer MP, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20(S2):1\u201326.","journal-title":"Clin Microbiol Infect"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-017-0151-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-017-0151-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-017-0151-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T06:30:57Z","timestamp":1603175457000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-017-0151-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["151"],"URL":"https:\/\/doi.org\/10.1007\/s11938-017-0151-1","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,24]]}}}